HLB Therapeutics Co.,Ltd.
Biopharmaceutical firm developing drugs for rare diseases in oncology and ophthalmology.
115450 | KO
Overview
Corporate Details
- ISIN(s):
- KR7115450009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 정자일로 248, 성남시
- Sector:
- Manufacturing
Description
HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's clinical-stage pipeline focuses on addressing unmet medical needs in ophthalmology and oncology. Key development programs include RGN-259, a therapeutic agent for Dry Eye Disease and Neurotrophic Keratopathy, and OKN-007 for the treatment of Glioblastoma Multiforme. Additionally, the company is advancing a Natural Killer (NK) cell therapy through late-stage clinical trials to provide new therapeutic options for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-09-23 00:00 |
주요사항보고서(회사분할결정)
|
Korean | 203.3 KB | ||
| 2024-08-20 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2024-08-14 00:00 |
반기보고서 (2024.06)
|
Korean | 1.7 MB | ||
| 2024-07-22 00:00 |
[기재정정]전환청구권행사 (제14회차, 제15회차)
|
Korean | 18.6 KB | ||
| 2024-07-10 00:00 |
전환청구권행사 (제14회차, 제15회차)
|
Korean | 15.0 KB | ||
| 2024-07-01 00:00 |
전환가액의조정 (제16회차)
|
Korean | 10.9 KB | ||
| 2024-05-22 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.0 KB | ||
| 2024-05-22 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 106.2 KB | ||
| 2024-05-16 00:00 |
분기보고서 (2024.03)
|
Korean | 1.5 MB | ||
| 2024-04-02 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.8 KB | ||
| 2024-04-02 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 121.0 KB | ||
| 2024-04-02 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.2 KB | ||
| 2024-04-01 00:00 |
증권발행결과(자율공시) (제3자배정 유상증자)
|
Korean | 6.4 KB | ||
| 2024-04-01 00:00 |
증권발행결과(자율공시) (제16회차 CB)
|
Korean | 6.0 KB | ||
| 2024-03-27 00:00 |
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 73.3 KB |
Automate Your Workflow. Get a real-time feed of all HLB Therapeutics Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HLB Therapeutics Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HLB Therapeutics Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
